Get the Stockscreener App
1.08
1.89%
0.02
After Hours:
1.10
0.02
+1.85%
Curis Inc stock is traded at $1.08, with a volume of 186.18K.
It is up +1.89% in the last 24 hours and up +18.03% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.06
Open:
$1.09
24h Volume:
186.18K
Relative Volume:
0.41
Market Cap:
$13.96M
Revenue:
$11.41M
Net Income/Loss:
$-38.92M
P/E Ratio:
-0.2212
EPS:
-4.8828
Net Cash Flow:
$-30.46M
1W Performance:
+18.60%
1M Performance:
+18.03%
6M Performance:
-34.55%
1Y Performance:
-65.93%
1-Day Range:
$1.0444
$1.11
1-Week Range:
$0.9201
$1.11
52-Week Range:
$0.771
$3.4094
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.08 | 13.70M | 11.41M | -38.92M | -30.46M | -4.8828 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
Support Test: Will Curis Inc benefit from AI trendsTrade Analysis Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target - Yahoo Finance
Curis regains compliance with Nasdaq listing standards, enters monitoring period - Investing.com
Curis Regains Nasdaq Compliance, Remains Under Monitoring Period - TipRanks
Curis (CRIS) targets major share hike to unlock PIPE and new 2026 equity plan - Stock Titan
Curis Advances Clinical Pipeline with Focus on Leukemia Treatments - AD HOC NEWS
Buyout Rumor: Is Curis Inc a potential multi bagger2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Rate Cut: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Curis (CRIS) to Release Earnings on Wednesday - Defense World
Panic Selling: Is Curis Inc exposed to political riskQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Is Curis Inc stock a value trap2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Is Curis Inc. stock a value trapJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch - TipRanks
Bond Watch: Is Curis Inc exposed to political risk2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Curis shares jump after lining up up to $80.8m in private placement financing - MSN
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - marketscreener.com
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset - Yahoo Finance
Curis closes private placement for up to $80.8 million in funding - Investing.com Nigeria
Curis announces closing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Stock Market Recap: Can Curis Inc. stock beat analyst upgradesQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Curis Inc. (CUS0) stock a top dividend aristocrat candidateJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Curis prices private placement of $80.8M - MSN
Volume Recap: Can Curis Inc. stock maintain growth trajectoryEntry Point & Consistent Income Trade Recommendations - ulpravda.ru
Curis (NASDAQ: CRIS) sets PIPE financing with warrants and targets 2027 cash runway - Stock Titan
Curis Announces PIPE Financing and Strategic Capital Strengthening - TipRanks
Curis Signs Multiple Material Agreements - TradingView — Track All Markets
Curis announces $80.8 million private placement to fund drug development By Investing.com - Investing.com Nigeria
Curis Inc: Can This Beaten-Down Cancer Stock Still Surprise The Market? - AD HOC NEWS
Aug Breakouts: Can Curis Inc stock maintain growth trajectoryDividend Hike & Daily Profit Maximizing Trade Tips - moha.gov.vn
Curis, Inc. announced that it expects to receive $20.195 million in funding - marketscreener.com
Curis announces $80.8M private placement - TipRanks
Crude Oil Down 2%; ISM Services PMI Surges In December - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Curis (CRIS) Secures PIPE Deal for Up to $80.8M - GuruFocus
Curis announces pricing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Curis stock soars after securing $80.8 million private placement deal By Investing.com - Investing.com South Africa
Curis stock soars after securing $80.8 million private placement deal - Investing.com India
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PR Newswire
Can Curis Inc stock maintain growth trajectoryWeekly Investment Recap & Reliable Breakout Stock Forecasts - moha.gov.vn
Why Investors Shouldn't Be Surprised By Curis, Inc.'s (NASDAQ:CRIS) 27% Share Price Plunge - simplywall.st
ETF Watch: Will PWV stock outperform global peersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
CUS0 Stock Price and Chart — TRADEGATE:CUS0 - TradingView — Track All Markets
Can Curis Inc. stock attract ESG capital inflowsWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Is Curis Inc. stock a contrarian buyJuly 2025 Selloffs & Safe Entry Point Alerts - Улправда
Will Curis Inc. stock remain a Wall Street favoriteJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - DonanımHaber
Can Curis Inc. stock sustain market leadershipJuly 2025 Recap & Consistent Profit Trade Alerts - Улправда
Alert incorrectly tagged to Curis Inc withdrawn - marketscreener.com
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):